Screener
10x Genomics, Inc. TXG Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Products and services revenue | $149,094 | $145,157 | $298,990 | $282,980 |
| License and royalty revenue | 1,942 | 27,751 | 2,889 | 44,811 |
| Revenue | 151,036 | 172,908 | 301,879 | 327,791 |
| Cost of products and services revenue | 38,539 | 47,824 | 83,204 | 97,262 |
| Gross profit | 112,497 | 125,084 | 218,675 | 230,529 |
| Operating expenses: | ||||
| Research and development | 56,791 | 61,224 | 113,638 | 125,469 |
| Selling, general and administrative | 78,661 | 74,434 | 145,038 | 164,162 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s total revenue?
- 10x Genomics, Inc. (TXG) reported total revenue of $151.04M in Q2 2026.
- How has 10x Genomics, Inc.'s total revenue changed year-over-year?
- 10x Genomics, Inc.'s total revenue decreased by 12.6% year-over-year, from $172.91M to $151.04M.
- What is the long-term trend for 10x Genomics, Inc.'s total revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s total revenue has grown at a 7.0% compound annual growth rate (CAGR), from $490.49M to $642.82M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about 10x Genomics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude